Health and Healthcare

Celgene : CELG

All CELG Articles

433 Articles

Jon C. Ogg | Apr 2, 2014 at 8:20 AM EDT

Large Cap Biotechs Trading With Only Big Pharma P/E Ratios

In a new report from RBC, its analysts say that biotech stocks trading at some of the lowest forward multiples…

Jon C. Ogg | Mar 27, 2014 at 8:55 AM EDT

Morgan Stanley Starts Mixed Coverage on Top Biotech Stocks

courtesy of Morgan StanleyLike many of its Wall Street peers, the brutal sell-off in the biotechnology space has Morgan Stanley…

Trey Thoelcke | Mar 26, 2014 at 7:25 AM EDT

Short Sellers Find Renewed Interest in Biotech Stocks

After retreating from many leading biotech and emerging pharmaceutical stocks in the previous two periods, short sellers returned in early…

Trey Thoelcke | Mar 24, 2014 at 9:55 AM EDT

Top Biotechnology Stocks On Sale Again

For the second time in less than a month, the biotechnology sector got whacked when once again, chatter coming from…

Trey Thoelcke | Mar 12, 2014 at 7:10 AM EDT

Short Sellers Retreat From Biotech Stocks Again

Biotech and emerging pharmaceutical stocks continue to be hot, but short sellers shied away from many of them in late…

Trey Thoelcke | Feb 27, 2014 at 7:00 AM EST

Short Sellers Return to Biotech Stocks

After largely shying away in the previous period, short sellers returned to many of the leading biotech and emerging pharmaceutical…

Trey Thoelcke | Feb 12, 2014 at 6:50 AM EST

Short Sellers Shy Away From Biotechs

24/7 Wall St. has tracked the short interest in leading biotech and emerging pharmaceutical stocks. By and large, short sellers…

cgblaine22 | Jan 29, 2014 at 12:10 PM EST

Why Caution Is Prevailing in Biotechs Into and After Earnings

Biogen Idec surprised investors Wednesday with weaker-than-expected guidance for 2014 earnings. Amgen beat estimates late Tuesday. Celgene and Gilead Sciences…

Trey Thoelcke | Jan 29, 2014 at 8:15 AM EST

UBS Says Buy Top Biotech Stocks in Front of Earnings for Big Upside

Like many firms on Wall Street, the biotechnology team at UBS thinks that most of the top mega-cap and large…

Trey Thoelcke | Jan 22, 2014 at 9:05 AM EST

Cowen Top Biotech Stocks to Buy for 2014 With Huge Upside

Here are some of the top biotech names to buy at Cowen. They presented such an extensive list that we…

Jon C. Ogg | Jan 13, 2014 at 12:10 PM EST

Higher 2017 Celgene Guidance Keeps Confusion in Near-Term

Celgene has issued its preliminary numbers ahead of its presentations at the 32nd Annual J.P. Morgan Healthcare Conference. There is…

Jon C. Ogg | Jan 6, 2014 at 8:35 AM EST

Top Analyst Downgrades, Stocks to Sell: Apple, Twitter, First Solar and More

These are the top analyst downgrades and cautious research notes from Wall Street for Monday, January 6.

Trey Thoelcke | Dec 19, 2013 at 8:30 AM EST

Cowen Forecasts Top 10 Potential Biotech Surprises for 2014

The Cowen biotechnology team has a list of top 10 surprises that are specific to the very hot biotechnology sector.

Lee Jackson | Dec 11, 2013 at 9:00 AM EST

Credit Suisse Offers Top Biotech Stocks to Buy for 2014

ThinkstockCredit Suisse is out and pounding the table that biotechnology cannot be ignored in 2014. Biotech has been the top-performing…

Jon C. Ogg | Dec 10, 2013 at 8:40 AM EST

Top Analyst Upgrades and Downgrades: Apple, 3D Systems, Celgene, Goldman, Geron and More

Jon OggStocks are looking for direction after the first week of a sell-off on the heels of eight weeks of…

1 … 20 21 22 23 24 … 29

Celgene : CELG

All CELG Articles

Large Cap Biotechs Trading With Only Big Pharma P/E Ratios

Morgan Stanley Starts Mixed Coverage on Top Biotech Stocks

Short Sellers Find Renewed Interest in Biotech Stocks

Top Biotechnology Stocks On Sale Again

Short Sellers Retreat From Biotech Stocks Again

Short Sellers Return to Biotech Stocks

Short Sellers Shy Away From Biotechs

Why Caution Is Prevailing in Biotechs Into and After Earnings

UBS Says Buy Top Biotech Stocks in Front of Earnings for Big Upside

Cowen Top Biotech Stocks to Buy for 2014 With Huge Upside

Higher 2017 Celgene Guidance Keeps Confusion in Near-Term

Top Analyst Downgrades, Stocks to Sell: Apple, Twitter, First Solar and More

Cowen Forecasts Top 10 Potential Biotech Surprises for 2014

Credit Suisse Offers Top Biotech Stocks to Buy for 2014

Top Analyst Upgrades and Downgrades: Apple, 3D Systems, Celgene, Goldman, Geron and More

Wall Street Strategist: Stock Market Just Became a “Buyer’s Dream” After Recent Pull-Back

How Low Will XRP Go in 2026? Prediction Markets Give XRP a 70% Chance of Falling Below $1

Got $1,500? This Invisible Megatrend Makes 1 Serial Compounder a Clear Buy Right Now

Why Delaying Social Security While Emptying Your 401(k) Can Slash Your Lifetime Taxes

Retiring With $1.8M in New Jersey Means an $11,400 Annual Tax Bill the Calculators Skip

Wall Street Strategist: Stock Market Just Became a “Buyer’s Dream” After Recent Pull-Back

How Low Will XRP Go in 2026? Prediction Markets Give XRP a 70% Chance of Falling Below $1

Celgene : CELG

All CELG Articles

Large Cap Biotechs Trading With Only Big Pharma P/E Ratios

Morgan Stanley Starts Mixed Coverage on Top Biotech Stocks

Short Sellers Find Renewed Interest in Biotech Stocks

Top Biotechnology Stocks On Sale Again

Short Sellers Retreat From Biotech Stocks Again

Short Sellers Return to Biotech Stocks

Short Sellers Shy Away From Biotechs

Why Caution Is Prevailing in Biotechs Into and After Earnings

UBS Says Buy Top Biotech Stocks in Front of Earnings for Big Upside

Cowen Top Biotech Stocks to Buy for 2014 With Huge Upside

Higher 2017 Celgene Guidance Keeps Confusion in Near-Term

Top Analyst Downgrades, Stocks to Sell: Apple, Twitter, First Solar and More

Cowen Forecasts Top 10 Potential Biotech Surprises for 2014

Credit Suisse Offers Top Biotech Stocks to Buy for 2014

Top Analyst Upgrades and Downgrades: Apple, 3D Systems, Celgene, Goldman, Geron and More

Wall Street Strategist: Stock Market Just Became a “Buyer’s Dream” After Recent Pull-Back

How Low Will XRP Go in 2026? Prediction Markets Give XRP a 70% Chance of Falling Below $1

Got $1,500? This Invisible Megatrend Makes 1 Serial Compounder a Clear Buy Right Now

Featured Reads

Why Delaying Social Security While Emptying Your 401(k) Can Slash Your Lifetime Taxes

Retiring With $1.8M in New Jersey Means an $11,400 Annual Tax Bill the Calculators Skip